Oncotarget cover image

HER3: A Vital Target in Cancer Treatment

Oncotarget

00:00

Challenges in Translating Preclinical Studies on HER3 Targeted Therapies to Clinical Trials

Exploring the challenges in translating preclinical studies on HER3 targeted therapies to clinical trials, including the lack of HER3 expression screening in previous trials. Emphasizing the importance of identifying HER3 expression and gene fusions as predictive biomarkers and discussing alternative HER3 activating mechanisms and compensatory tumor cell responses.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app